Your search returned 2 results.

Results
	1.	Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. [electronic resource] by Stone, John H Carruthers, Mollie N Topazian, Mark D Khosroshahi, Arezou Witzig, Thomas E Wallace, Zachary S Hart, Phillip A Deshpande, Vikram Smyrk, Thomas C Chari, Suresh Producer: 20151001 In: Annals of the rheumatic diseases vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. [electronic resource] by Wallace, Zachary S Naden, Ray P Chari, Suresh Choi, Hyon K Della-Torre, Emanuel Dicaire, Jean-Francois Hart, Phillip A Inoue, Dai Kawano, Mitsuhiro Khosroshahi, Arezou Lanzillotta, Marco Okazaki, Kazuichi Perugino, Cory A Sharma, Amita Saeki, Takako Schleinitz, Nicolas Takahashi, Naoki Umehara, Hisanori Zen, Yoh Stone, John H Producer: 20200420 In: Annals of the rheumatic diseases vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search